https://www.fortunebusinessinsights.com/u-s-genetic-testing-market-105034


https://www.fortunebusinessinsights.com/u-s-genetic-testing-market-105034

The U.S. genetic testing market was valued at USD 4.11 billion in 2019. The COVID-19 pandemic had
an unprecedented and significant impact, causing a decline in demand for genetic testing. In 2020, the
market experienced a lower growth rate of 6.7%, compared to the average year-on-year growth seen
between 2016 and 2019. However, the market is expected to recover, growing from USD 4.38 billion in
2020 to USD 10.29 billion by 2027, with a compound annual growth rate (CAGR) of 13.0% during the
2020-2027 period. This increase in CAGR reflects the anticipated rebound in demand and the return to
pre-pandemic growth levels as the effects of the pandemic subside.
Read More : https://www.fortunebusinessinsights.com/u-s-genetic-testing-market-105034
Top Companies in the U.S. Genetic Testing Market

Invitae Corporation (San Francisco, U.S.)
 Ambry Genetics (Aliso Viejo, U.S.)
 BioReference Laboratories, Inc. (Elmwood Park, U.S.)
 Progenity, Inc. (San Diego, U.S.)
 Quest Diagnostics Incorporated (Secaucus, U.S.)
 Myriad Genetics, Inc. (Salt Lake City, U.S.)
 Fulgent Genetics (Temple City, U.S.)
 Burning Rock Biotech Limited (Guangzhou, China)
Key Industry Development
In April 2021, Invitae Corporation announced the availability of their sponsored genetic testing program
for patients at risk of developing certain adult neurodegenerative conditions. This program, offered free of
cost in the U.S., Canada, Australia, and Brazil, aims to assist at-risk individuals who struggle with
diagnosing these complex conditions. This initiative highlights the growing emphasis on early detection
and personalized healthcare in the U.S. genetic testing market, further fueling the market's expansion.
Market Drivers & Restraints
Market Drivers
The U.S. genetic testing market is propelled by several critical factors:
 Rising Prevalence of Genetic Disorders: An increasing number of patients with hereditary and
genetic conditions has boosted demand for genetic testing solutions.
 Advancements in Genomic Technologies: Breakthroughs in next-generation sequencing (NGS)
and CRISPR technologies are driving innovation in genetic testing.
 Growing Awareness of Personalized Medicine: Consumers and healthcare providers are
increasingly adopting genetic tests to tailor treatments to individual patient needs.
 Favorable Government Initiatives: Government programs promoting early detection and
diagnosis of genetic conditions are supporting market growth.
Market Restraints
While the genetic testing market is growing rapidly, certain challenges remain:
 High Costs of Genetic Testing: Advanced genetic tests can be expensive, limiting accessibility
for some patients.
 Complexity in Interpretation: The complexity of genetic data and results can pose challenges
for both patients and healthcare professionals.
 Ethical and Privacy Concerns: Concerns over the privacy of genetic information and ethical
issues related to genetic testing may hinder adoption.
Market Report Coverage
The U.S. genetic testing market report provides a detailed analysis of the following aspects:
 Market dynamics, including growth drivers, restraints, and opportunities.
 Detailed segmentation by type, application, and technology.

Insights into key players and competitive strategies.
 Comprehensive regional analysis and growth prospects in the U.S.
Market Competitive Landscape
The U.S. genetic testing market is highly competitive, with major players focusing on innovation,
strategic collaborations, and geographic expansion. Companies like Invitae Corporation and Quest
Diagnostics are leading the charge by offering advanced genetic testing solutions, supported by extensive
R&D efforts. Meanwhile, emerging players are leveraging cutting-edge technologies to carve out their
niches in this rapidly evolving market.
Market Segments
DNA Sequencing Leads the Way
The DNA sequencing segment is expected to dominate the U.S. genetic testing market during the forecast
period. Advances in next-generation sequencing (NGS) technology have revolutionized genetic
diagnostics, enabling faster, more accurate, and cost-effective testing. DNA sequencing is widely used for
applications such as hereditary testing, prenatal screening, and oncology, further solidifying its leadership
in the market.
Market Regional Insights
The U.S. genetic testing market benefits from a robust healthcare infrastructure and widespread adoption
of advanced medical technologies. Key highlights include:
 High Adoption Rates: The U.S. boasts one of the highest adoption rates of genetic testing
globally, driven by consumer awareness and healthcare provider recommendations.
 Strong Research Ecosystem: A well-established research and development ecosystem supports
innovation in genetic testing technologies.
 Growing Direct-to-Consumer Testing: Companies offering direct-to-consumer genetic tests
have gained popularity, catering to the rising interest in ancestry and health-related genetic
information.
Future Market Scope

https://www.fortunebusinessinsights.com/checkout-page/105034

The U.S. genetic testing market is poised for significant growth in the coming years. Technological
advancements, combined with increasing consumer awareness and a growing emphasis on early
diagnosis, are expected to drive market expansion. Innovations such as multi-gene panel testing and non-
invasive testing methods are likely to further enhance market growth. As healthcare providers and
consumers embrace the potential of genetic testing in personalized medicine, the market is set to play a
critical role in transforming healthcare delivery in the U.S.
Purchase Full Report at - https://www.fortunebusinessinsights.com/checkout-page/105034
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of
all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address
challenges distinct to their businesses. Our goal is to empower our clients with holistic market
intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique
mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team
of experienced analysts and consultants use industry-leading research tools and techniques to compile
comprehensive market studies, interspersed with relevant data.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
9th Floor, Icon Tower,
Baner - Mahalunge Road,
Baner, Pune-411045,
Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com